Symbols / AVR Stock $5.90 +3.87% Anteris Technologies Global Corp.

Healthcare • Medical Instruments & Supplies • Australia • NGM
AVR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Wayne Geoffrey Paterson
Exch · Country NGM · Australia
Market Cap 573.67M
Enterprise Value 563.72M
Income -94.14M
Sales 1.91M
FCF (ttm) -44.25M
Book/sh -0.00
Cash/sh 0.12
Employees 174
Insider 10d —
IPO Dec 13, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -6.08
PEG —
P/S 299.88
P/B -2,950.00
P/C —
EV/EBITDA -6.11
EV/Sales 294.68
Quick Ratio 0.58
Current Ratio 0.73
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -2.55
EPS next Y -0.97
EPS Growth —
Revenue Growth -42.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-11
Earnings (prior) 2026-02-26
ROA -113.18%
ROE -3.02%
ROIC —
Gross Margin 70.26%
Oper. Margin -93.44%
Profit Margin 0.00%
Shs Outstand 97.23M
Shs Float 78.52M
Insider Own 16.51%
Instit Own 33.79%
Short Float 6.08%
Short Ratio 3.96
Short Interest 4.13M
52W High 6.95
vs 52W High -15.10%
52W Low 2.85
vs 52W Low 107.02%
Beta 0.55
Impl. Vol. 44.41%
Rel Volume 0.76
Avg Volume 909.90K
Volume 692.39K
Target (mean) $15.75
Tgt Median $15.50
Tgt Low $15.00
Tgt High $17.00
# Analysts 4
Recom Strong_buy
Prev Close $5.68
Price $5.90
Change 3.87%
About

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$15.75
Mean price target
2. Current target
$5.90
Latest analyst target
3. DCF / Fair value
$-8.19
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.90
Low
$15.00
High
$17.00
Mean
$15.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-27 reit Cantor Fitzgerald Overweight → Overweight $15
2026-03-11 init Wells Fargo — → Overweight $16
2025-01-08 init Lake Street — → Buy $20
2025-01-07 init TD Cowen — → Buy $15
2025-01-07 init Cantor Fitzgerald — → Overweight $9
2025-01-07 init Barclays — → Overweight $22
News
RSS: Latest AVR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-22 L1 CAPITAL PTY. LTD. Beneficial Owner of more than 10% of a Class of Security — 5,000,000 $5.75 $28,750,000
2025-12-16 SEABERG JOHN D Director — 27,777 — —
2025-12-16 PATERSON WAYNE Chief Executive Officer — 333,333 — —
2025-12-16 ST DENIS DAVID Chief Operating Officer — 166,666 — —
2025-12-16 MCDONNELL MATTHEW Chief Financial Officer — 27,777 — —
2025-03-11 DENARO STEPHEN Director — 16,500 $7.13 $117,645
2025-03-06 SEABERG JOHN D Director — 40,000 $7.13 $285,200
2025-03-05 PATERSON WAYNE Chief Executive Officer — 233,000 $7.13 $1,661,290
2024-12-16 SEABERG JOHN D Director — 15,858 $0.00 $0
2024-12-16 PATERSON WAYNE Chief Executive Officer — 20,334 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Revenue
2.73
-14.56%
3.20
-45.10%
5.83
Operating Revenue
2.73
-14.56%
3.20
-45.10%
5.83
Cost Of Revenue
1.86
-35.98%
2.90
-26.06%
3.93
Reconciled Cost Of Revenue
1.02
-56.88%
2.35
-30.11%
3.37
Gross Profit
0.88
+193.85%
0.30
-84.34%
1.91
Operating Expense
47.53
+49.54%
31.79
+74.40%
18.23
Research And Development
30.89
+75.61%
17.59
+75.99%
9.99
Selling General And Administration
17.05
+12.04%
15.21
+66.53%
9.14
Selling And Marketing Expense
1.09
+34.72%
0.81
+94.50%
0.41
General And Administrative Expense
15.96
+10.77%
14.41
+65.20%
8.72
Salaries And Wages
9.86
+37.64%
7.17
+39.58%
5.13
Other Gand A
5.26
-20.33%
6.60
+113.53%
3.09
Other Operating Expenses
-0.72
+42.33%
-1.24
-25.90%
-0.99
Total Expenses
49.39
+42.39%
34.69
+56.60%
22.15
Operating Income
-46.66
-48.17%
-31.49
-92.93%
-16.32
Total Operating Income As Reported
-48.14
-54.72%
-31.11
-84.54%
-16.86
EBITDA
-45.54
-56.27%
-29.14
-88.05%
-15.50
Normalized EBITDA
-44.28
-45.18%
-30.50
-95.46%
-15.61
Reconciled Depreciation
1.16
+49.56%
0.77
+20.93%
0.64
EBIT
-46.70
-56.10%
-29.92
-85.38%
-16.14
Total Unusual Items
-1.26
-192.48%
1.36
+1156.74%
0.11
Total Unusual Items Excluding Goodwill
-1.26
-192.48%
1.36
+1156.74%
0.11
Special Income Charges
-0.63
0.00
—
Other Special Charges
0.13
—
—
Net Income
-46.02
-50.58%
-30.56
-78.00%
-17.17
Pretax Income
-46.76
-53.00%
-30.56
-78.00%
-17.17
Net Non Operating Interest Income Expense
0.36
+182.35%
-0.44
+54.61%
-0.97
Interest Expense Non Operating
0.07
-89.66%
0.65
-37.27%
1.03
Net Interest Income
0.36
+182.35%
-0.44
+54.61%
-0.97
Interest Expense
0.07
-89.66%
0.65
-37.27%
1.03
Interest Income Non Operating
0.43
+103.47%
0.21
+206.89%
0.07
Interest Income
0.43
+103.47%
0.21
+206.89%
0.07
Other Income Expense
-0.47
-134.35%
1.36
+1078.91%
0.12
Other Non Operating Income Expenses
0.79
+38344.04%
0.00
-71.92%
0.01
Gain On Sale Of Security
-0.63
-145.95%
1.36
+1156.74%
0.11
Tax Provision
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-46.76
-53.00%
-30.56
-78.00%
-17.17
Net Income From Continuing Operation Net Minority Interest
-46.02
-50.58%
-30.56
-78.00%
-17.17
Net Income From Continuing And Discontinued Operation
-46.02
-50.58%
-30.56
-78.00%
-17.17
Net Income Continuous Operations
-46.76
-53.00%
-30.56
-78.00%
-17.17
Minority Interests
0.74
0.00
—
Normalized Income
-44.76
-40.22%
-31.92
-84.75%
-17.28
Net Income Common Stockholders
-46.02
-50.58%
-30.56
-78.00%
-17.17
Diluted EPS
-2.94
-30.01%
-2.26
—
Basic EPS
-2.94
-30.01%
-2.26
—
Basic Average Shares
15.61
+16.79%
13.36
—
Diluted Average Shares
15.61
+16.79%
13.36
—
Diluted NI Availto Com Stockholders
-46.02
-50.58%
-30.56
-78.00%
-17.17
Depreciation Amortization Depletion Income Statement
0.31
+39.13%
0.23
+169.96%
0.08
Depreciation And Amortization In Income Statement
0.31
+39.13%
0.23
+169.96%
0.08
Gain On Sale Of PPE
-0.50
0.00
—
Insurance And Claims
0.84
+30.58%
0.64
+29.38%
0.50
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Assets
30.53
+90.97%
15.99
-25.42%
21.43
Current Assets
24.22
+97.90%
12.24
-34.72%
18.75
Cash Cash Equivalents And Short Term Investments
21.03
+126.27%
9.29
-39.87%
15.46
Cash And Cash Equivalents
21.03
+126.27%
9.29
-39.87%
15.46
Cash Equivalents
8.01
0.00
-100.00%
0.06
Cash Financial
13.01
+40.02%
9.29
-39.62%
15.39
Receivables
1.85
+21.84%
1.51
-18.22%
1.85
Accounts Receivable
0.41
-7.57%
0.44
+115.10%
0.20
Other Receivables
0.72
+489.72%
0.12
-84.24%
0.78
Taxes Receivable
0.71
-24.92%
0.95
+9.53%
0.87
Inventory
0.44
+24.39%
0.36
-35.32%
0.55
Raw Materials
0.26
-2.23%
0.27
+7.95%
0.25
Work In Process
0.05
-34.90%
0.08
-57.70%
0.19
Finished Goods
0.13
+2296.65%
0.01
-95.06%
0.11
Prepaid Assets
0.85
-16.84%
1.02
+13.93%
0.89
Restricted Cash
0.06
+2.53%
0.06
—
Total Non Current Assets
6.31
+68.34%
3.75
+39.53%
2.68
Net PPE
5.48
+74.55%
3.14
+63.38%
1.92
Gross PPE
9.06
+55.32%
5.83
+32.98%
4.39
Accumulated Depreciation
-3.58
-32.92%
-2.70
-9.30%
-2.47
Machinery Furniture Equipment
7.08
+44.81%
4.89
+33.50%
3.66
Construction In Progress
0.49
0.00
—
Other Properties
1.49
+57.59%
0.94
+30.35%
0.72
Goodwill And Other Intangible Assets
0.41
-32.47%
0.61
-20.47%
0.76
Other Intangible Assets
0.41
-32.47%
0.61
-20.47%
0.76
Non Current Accounts Receivable
0.42
—
—
Total Liabilities Net Minority Interest
11.63
+67.27%
6.95
-36.27%
10.91
Current Liabilities
9.46
+56.43%
6.05
-40.71%
10.20
Payables And Accrued Expenses
7.01
+77.17%
3.96
-13.02%
4.55
Payables
3.14
+81.78%
1.73
-22.53%
2.23
Accounts Payable
3.14
+81.78%
1.73
-22.53%
2.23
Current Accrued Expenses
3.87
+73.61%
2.23
-3.89%
2.32
Employee Benefits
0.68
+2116.20%
0.03
+0.65%
0.03
Pensionand Other Post Retirement Benefit Plans Current
0.85
+33.57%
0.64
+23.73%
0.51
Current Debt And Capital Lease Obligation
0.67
+30.39%
0.51
-86.61%
3.83
Current Debt
—
—
3.38
Other Current Borrowings
—
—
3.38
Current Capital Lease Obligation
0.67
+30.39%
0.51
+13.08%
0.45
Other Current Liabilities
0.92
-1.48%
0.94
-27.96%
1.30
Total Non Current Liabilities Net Minority Interest
2.17
+139.58%
0.91
+27.33%
0.71
Long Term Debt And Capital Lease Obligation
1.02
+132.08%
0.44
+43.81%
0.31
Long Term Debt
0.09
—
—
Long Term Capital Lease Obligation
0.93
+110.74%
0.44
+43.81%
0.31
Long Term Provisions
0.47
+7.94%
0.44
+16.09%
0.38
Non Current Pension And Other Postretirement Benefit Plans
0.05
+56.65%
0.03
—
Other Non Current Liabilities
0.09
—
—
Stockholders Equity
19.30
+113.67%
9.03
-14.17%
10.52
Common Stock Equity
19.30
+113.67%
9.03
-14.17%
10.52
Capital Stock
217.33
+28.00%
169.79
+20.02%
141.47
Common Stock
217.33
+28.00%
169.79
+20.02%
141.47
Share Issued
35.94
+0.00%
35.94
+0.00%
35.94
Ordinary Shares Number
35.94
+0.00%
35.94
+0.00%
35.94
Additional Paid In Capital
11.63
+257.02%
3.26
+919.88%
0.32
Retained Earnings
-200.10
-29.87%
-154.07
-24.75%
-123.51
Gains Losses Not Affecting Retained Earnings
-9.56
+3.84%
-9.94
-28.20%
-7.75
Minority Interest
-0.40
0.00
—
Other Equity Adjustments
-9.56
+3.84%
-9.94
-28.20%
-7.75
Total Equity Gross Minority Interest
18.90
+109.21%
9.03
-14.17%
10.52
Total Capitalization
19.39
+114.70%
9.03
-14.17%
10.52
Working Capital
14.77
+138.37%
6.19
-27.57%
8.55
Invested Capital
19.39
+114.70%
9.03
-35.02%
13.90
Total Debt
1.69
+77.33%
0.95
-76.96%
4.14
Capital Lease Obligations
1.60
+67.48%
0.95
+25.45%
0.76
Net Tangible Assets
18.89
+124.20%
8.43
-13.68%
9.76
Tangible Book Value
18.89
+124.20%
8.43
-13.68%
9.76
Inventories Adjustments Allowances
0.00
0.00
0.00
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-34.63
-17.73%
-29.42
-103.74%
-14.44
Cash Flow From Continuing Operating Activities
-34.63
-17.73%
-29.42
-103.74%
-14.44
Net Income From Continuing Operations
-46.76
-53.00%
-30.56
-78.00%
-17.17
Depreciation Amortization Depletion
1.16
+49.56%
0.77
+20.93%
0.64
Depreciation
0.95
+66.17%
0.57
+30.97%
0.44
Amortization Cash Flow
0.20
+1.93%
0.20
-0.86%
0.20
Depreciation And Amortization
1.16
+49.56%
0.77
+20.93%
0.64
Amortization Of Intangibles
0.20
+1.93%
0.20
-0.86%
0.20
Other Non Cash Items
0.10
-81.24%
0.54
-42.25%
0.94
Stock Based Compensation
5.76
+96.11%
2.94
+1052.45%
0.25
Operating Gains Losses
1.13
+182.81%
-1.36
-1630.34%
-0.08
Gain Loss On Investment Securities
-0.01
-103.70%
0.26
-24.41%
0.34
Net Foreign Currency Exchange Gain Loss
0.63
+139.24%
-1.62
-260.70%
-0.45
Gain Loss On Sale Of PPE
0.50
0.00
-100.00%
0.03
Change In Working Capital
3.99
+328.20%
-1.75
-278.91%
0.98
Change In Receivables
-0.35
+35.37%
-0.53
-724.71%
0.09
Changes In Account Receivables
-0.35
+35.37%
-0.53
-724.71%
0.09
Change In Inventory
-0.09
-144.66%
0.19
+1335.89%
-0.02
Change In Payables And Accrued Expense
4.42
+413.94%
-1.41
-255.21%
0.91
Investing Cash Flow
-2.58
-160.10%
-0.99
-12.02%
-0.89
Cash Flow From Continuing Investing Activities
-2.58
-160.10%
-0.99
-12.02%
-0.89
Net PPE Purchase And Sale
-2.36
-50.32%
-1.57
-178.16%
-0.56
Purchase Of PPE
-2.39
-51.66%
-1.57
-174.89%
-0.57
Sale Of PPE
0.03
+667.33%
0.00
-57.09%
0.01
Capital Expenditure
-2.39
-43.75%
-1.67
-186.14%
-0.58
Net Investment Purchase And Sale
—
0.00
+100.00%
-0.31
Purchase Of Investment
—
0.00
+100.00%
-0.31
Net Business Purchase And Sale
-0.21
0.00
—
Purchase Of Business
-0.21
0.00
—
Net Intangibles Purchase And Sale
-0.01
-101.15%
0.58
+6278.89%
-0.01
Purchase Of Intangibles
-0.01
+92.72%
-0.09
-873.88%
-0.01
Financing Cash Flow
49.34
+112.02%
23.27
-15.13%
27.42
Cash Flow From Continuing Financing Activities
49.34
+112.02%
23.27
-15.13%
27.42
Net Issuance Payments Of Debt
-0.81
+17.16%
-0.98
-156.17%
1.74
Issuance Of Debt
—
0.00
-100.00%
3.82
Repayment Of Debt
-0.81
+17.16%
-0.98
+53.17%
-2.08
Long Term Debt Payments
-0.81
+17.16%
-0.98
-1968.66%
-0.05
Net Long Term Debt Issuance
-0.81
+17.16%
-0.98
-1968.66%
-0.05
Short Term Debt Issuance
—
0.00
-100.00%
3.82
Short Term Debt Payments
—
-0.94
+54.02%
-2.04
Net Short Term Debt Issuance
—
-0.94
-152.48%
1.78
Net Common Stock Issuance
52.82
+108.80%
25.30
-5.99%
26.91
Net Other Financing Charges
-2.68
-154.48%
-1.05
+14.33%
-1.23
Changes In Cash
12.13
+269.89%
-7.14
-159.02%
12.09
Effect Of Exchange Rate Changes
-0.39
-137.74%
1.04
+14967.51%
0.01
Beginning Cash Position
9.35
-39.48%
15.46
+360.84%
3.35
End Cash Position
21.09
+125.47%
9.35
-39.48%
15.46
Free Cash Flow
-37.03
-19.12%
-31.08
-106.94%
-15.02
Interest Paid Supplemental Data
0.04
+15.19%
0.03
-33.56%
0.05
Common Stock Issuance
52.82
+108.80%
25.30
-5.99%
26.91
Issuance Of Capital Stock
52.82
+108.80%
25.30
-5.99%
26.91
Sale Of Intangibles
0.00
-100.00%
0.67
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category